T. Rowe Price Health Care ETF
TMED
5 hedge funds and large institutions have $2.11M invested in T. Rowe Price Health Care ETF in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
4.31% less ownership
Funds ownership: 17.21% → 12.9% (-4.3%)
8% less capital invested
Capital invested by funds: $2.3M → $2.11M (-$187K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$320K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$697K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$63.1K |
TMED Hedge Fund Activity: Q4 2025 in Review
5 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in T. Rowe Price Health Care ETF (TMED) for Q4 2025, worth a combined $2.11M — down 8.1% from $2.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TMED positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $320K. The largest seller was Flow Traders U.S., cutting an estimated $697K.
- 5 institutional investors held T. Rowe Price Health Care ETF (TMED) as of Q4 2025, up from 3 in Q3 2025.
- Funds reported $2.11M of T. Rowe Price Health Care ETF stock for Q4 2025, down 8.1% quarter-over-quarter.
- 2 funds opened new T. Rowe Price Health Care ETF positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest T. Rowe Price Health Care ETF buyer in Q4 2025 was Commonwealth Equity Services, an estimated $320K added.
- The largest T. Rowe Price Health Care ETF seller in Q4 2025 was Flow Traders U.S., an estimated $697K sold.
Based on aggregated 13F filings for Q4 2025.